Field, Medical

Field Medical kündigt First-in-Human-Studien für die bahnbrechende FieldForce™ Ventricular Pulsed Field Ablation-Technologie an

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Field Medical, Inc. California

en | boerse | 67970421 |